[Treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Yanada
Masamitsu
M
Department of Hematology, Nagoya University Graduate School of Medicine.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate